Publication: Personalized radiotherapy of brain metastases: survival prediction by means of dichotomized or differentiated blood test results?
Personalized radiotherapy of brain metastases: survival prediction by means of dichotomized or differentiated blood test results?
Date
Date
Date
Citations
Nieder, C., Andratschke, N. H., & Grosu, A. L. (2023). Personalized radiotherapy of brain metastases: survival prediction by means of dichotomized or differentiated blood test results? Frontiers in Oncology, 13, 1156161. https://doi.org/10.3389/fonc.2023.1156161
Abstract
Abstract
Abstract
BACKGROUND AND OBJECTIVES
The validated LabBM score (laboratory parameters in patients with brain metastases) represents a widely applicable survival prediction model, which incorporates 5 blood test results (serum lactate dehydrogenase (LDH), C-reactive protein (CRP), albumin, platelets and hemoglobin). All tests are classified as normal or abnormal, without accounting for the wide range of abnormality observed in practice. We tested the hypothesis that improved stratification might be possible, if more granular test results are emp
Additional indexing
Creators (Authors)
- Nieder, Carsten
- Andratschke, Nicolaus H
- Grosu, Anca L
Volume
Volume
Volume
Page Range
Page Range
Page Range
Item Type
Item Type
Item Type
In collections
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Language
Language
Language
Publication date
Publication date
Publication date
Date available
Date available
Date available
ISSN or e-ISSN
ISSN or e-ISSN
ISSN or e-ISSN
OA Status
OA Status
OA Status
Free Access at
Free Access at
Free Access at
Publisher DOI
Citations
Nieder, C., Andratschke, N. H., & Grosu, A. L. (2023). Personalized radiotherapy of brain metastases: survival prediction by means of dichotomized or differentiated blood test results? Frontiers in Oncology, 13, 1156161. https://doi.org/10.3389/fonc.2023.1156161
